Bank of New York Mellon
PROK icon

Bank of New York Mellon’s ProKidney PROK Stock Holding History

Bank of New York Mellon’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$360K Buy
176,657
+165,465
+1,478% +$303K ﹤0.01% 3906
2026
Q1 		$20K Hold
11,192
– – ﹤0.01% 4176
2025
Q4 		$25.1K Hold
11,192
– – ﹤0.01% 4158
2025
Q3 		$27.1K Buy
11,192
+643
+6% +$1.71K ﹤0.01% 4153
2025
Q2 		$6.25K Sell
10,549
-229,124
-96% -$178K ﹤0.01% 4133
2025
Q1 		$210K Buy
239,673
+9,903
+4% +$13.7K ﹤0.01% 3870
2024
Q4 		$388K Buy
229,770
+39,275
+21% +$70.8K ﹤0.01% 3648
2024
Q3 		$366K Buy
190,495
+11,259
+6% +$25.6K ﹤0.01% 3668
2024
Q2 		$441K Buy
179,236
+55,266
+45% +$148K ﹤0.01% 3644
2024
Q1 		$203K Sell
123,970
-3,986
-3% -$5.86K ﹤0.01% 3926
2023
Q4 		$228K Hold
127,956
– – ﹤0.01% 3913
2023
Q3 		$586K Sell
127,956
-35,855
-22% -$343K ﹤0.01% 3463
2023
Q2 		$1.83M Buy
+163,811
New +$1.74M ﹤0.01% 2890

Other funds holding PROK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BU
Brown University Providence, Rhode Island $112M AUM 3.02% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
VIA
Virtus Investment Advisers Hartford, Connecticut $429M AUM 52.52% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
AHL
Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Bank of New York Mellon's PROK Position: Q2 2026 in Review

Bank of New York Mellon increased its ProKidney (PROK) stake by 1,478% in Q2 2026, buying an estimated $303K and bringing the position to 176,657 shares worth $360K. The position accounts for ﹤0.01% of the portfolio, ranked #3906.

Bank of New York Mellon first reported a position in PROK in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.83M in Q2 2023. 28 funds tracked by Wall St. Rank hold PROK as of Q2 2026.

  • Bank of New York Mellon held 176,657 shares of ProKidney worth $360K as of Q2 2026.
  • Bank of New York Mellon bought 165,465 ProKidney shares in Q2 2026, an estimated $303K.
  • ProKidney made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3906 holding.
  • Bank of New York Mellon first reported a position in ProKidney in Q2 2023 and has held it in 13 quarters since.
  • Bank of New York Mellon's ProKidney position peaked at $1.83M in Q2 2023.
  • 28 funds tracked by Wall St. Rank held ProKidney as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.